University of Glasgow - University news - UofG researchers to play a key role in major EU arthritis research project gla.ac.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gla.ac.uk Daily Mail and Mail on Sunday newspapers.
The University of Glasgow has entered into a research collaboration with pharmaceutical company Eli Lilly and Company, that aims to discover and validate t
3.30pm: Jaguar Land Rover’s electric dreams
Jaguar cars will be all-electric by 2025 and the entire Jaguar Land Rover range by 2030, the brands’ owner has said.
In a boost to UK vehicle manufacturing it said it would keep all three of its three British plants open as part of the strategy.
However, it has dropped plans to build an electric version of its XJ luxury saloon model, which was to have been built at its Castle Bromwich plant.
The company plans to spend about £2.5bn a year on new technology for its cars, including investment in hydrogen fuel technology.
It hopes the change will see it reverse last year’s record £3.6bn loss which forced it to lay off 4,500 staff worldwide.
Search jobs UofG Announces Research Collaboration with Lilly to Discover Potential New Drug Targets
The University of Glasgow has entered into a research collaboration with pharmaceutical company Eli Lilly and Company, that aims to discover and validate the next generation of drug targets for immunological diseases.
The £4.6million research collaboration, due to last four years, will work across four diseases – psoriatic arthritis, rheumatoid arthritis, fibrosis and vasculitis – and will be led by the University of Glasgow’s Institute of Infection, Immunity and Inflammation.
The collaboration will allow scientists from UofG and Lilly to work together in order to drive the research forward – a move researchers hope will help enable the identification of first-in-class therapeutics for people suffering with these devastating and costly conditions. For instance, rheumatoid arthritis alone affects 0.3-1% of people across the globe and it is estimate